Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

July 01, 2002; Volume 302,Issue 1

PERSPECTIVES IN PHARMACOLOGY

  • You have access
    Molecular Mechanisms for Heterologous Sensitization of Adenylate Cyclase
    Val J. Watts
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 1-7; DOI: https://doi.org/10.1124/jpet.302.1.1

ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

  • You have access
    Effect of Albumin and Cytosol on Enzyme Kinetics of Tolbutamide Hydroxylation and on Inhibition of CYP2C9 by Gemfibrozil in Human Liver Microsomes
    Jun-Sheng Wang, Xia Wen, Janne T. Backman and Pertti J. Neuvonen
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 43-49; DOI: https://doi.org/10.1124/jpet.302.1.43
  • You have access
    Metabolism and Disposition of Resveratrol in Rats: Extent of Absorption, Glucuronidation, and Enterohepatic Recirculation Evidenced by a Linked-Rat Model
    Jean-Francois Marier, Pascal Vachon, Ari Gritsas, Jie Zhang, Jean-Pierre Moreau and Murray P. Ducharme
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 369-373; DOI: https://doi.org/10.1124/jpet.102.033340

BEHAVIORAL PHARMACOLOGY

  • You have access
    α4β2 Nicotinic Acetylcholine Receptor Activation Ameliorates Impairment of Spontaneous Alternation Behavior in Stroke-Prone Spontaneously Hypertensive Rats, an Animal Model of Attention Deficit Hyperactivity Disorder
    Ken-ichi Ueno, Hiroko Togashi, Machiko Matsumoto, Satoshi Ohashi, Hideya Saito and Mitsuhiro Yoshioka
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 95-100; DOI: https://doi.org/10.1124/jpet.302.1.95
  • You have access
    Clocinnamox Distinguishes Opioid Agonists According to Relative Efficacy in Normal and Morphine-Treated Rats Trained to Discriminate Morphine
    Ellen A. Walker and Alice M. Young
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 101-110; DOI: https://doi.org/10.1124/jpet.302.1.101
  • You have access
    A Novel Method to Assess Initial Sensitivity and Acute Functional Tolerance to Hypnotic Effects of Ethanol
    Igor Ponomarev and John C. Crabbe
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 257-263; DOI: https://doi.org/10.1124/jpet.302.1.257
  • You have access
    Antagonism of the Antinociceptive and Discriminative Stimulus Effects of Heroin and Morphine by 3-Methoxynaltrexone and Naltrexone in Rhesus Monkeys
    Carrie A. Bowen, Bradford D. Fischer, Nancy K. Mello and S. Stevens Negus
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 264-273; DOI: https://doi.org/10.1124/jpet.302.1.264

CARDIOVASCULAR

  • You have access
    Endothelium-Independent Vasodilator Effects of the Flavonoid Quercetin and Its Methylated Metabolites in Rat Conductance and Resistance Arteries
    Francisco Pérez-Vizcaı́no, Manuel Ibarra, Angel L. Cogolludo, Juan Duarte, Francisco Zaragozá-Arnáez, Laura Moreno, Gustavo López-López and Juan Tamargo
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 66-72; DOI: https://doi.org/10.1124/jpet.302.1.66
  • You have access
    Differential Effects of Short and Prolonged Exposure to Carvedilol on Voltage-Dependent Na+ Channels in Cultured Bovine Adrenal Medullary Cells
    Koji Kajiwara, Toshihiko Yanagita, Yasuhide Nakashima, Akihiko Wada, Futoshi Izumi and Nobuyuki Yanagihara
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 212-218; DOI: https://doi.org/10.1124/jpet.302.1.212
  • You have access
    Atorvastatin Treatment Induced Peroxisome Proliferator-Activated Receptor α Expression and Decreased Plasma Nonesterified Fatty Acids and Liver Triglyceride in Fructose-Fed Rats
    Núria Roglans, Elena Sanguino, Cristina Peris, Marta Alegret, Manuel Vázquez, Tomás Adzet, Cristina Dı́az, Gonzalo Hernández, Juan C. Laguna and Rosa M. Sánchez
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 232-239; DOI: https://doi.org/10.1124/jpet.302.1.232
  • You have access
    Antiarrhythmic Efficacy of Combined IKs and β-Adrenergic Receptor Blockade
    Joseph J. Lynch, Joseph J. Salata, Audrey A. Wallace, Gary L. Stump, David B. Gilberto, Hossain Jahansouz, Nigel J. Liverton, Harold G. Selnick and David A. Claremon
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 283-289; DOI: https://doi.org/10.1124/jpet.302.1.283
  • You have access
    Open Channel Block by KCB-328 [1-(2-Amino-4-methanesulfonamidophenoxy)-2-[N-(3,4-dimethoxyphenethyl)-N-methylamino]ethane Hydrochloride] of the Heterologously Expressed HumanEther-a-go-go-Related Gene K+ Channels
    Jin-Bong Park, Han Choe, Yu-Kyung Lee, Ki-Chan Ha, Kyoung-Suk Rhee, Jae-Ki Ko, Chan-Uhng Joo, Soo-Wan Chae and Yong-Geun Kwak
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 314-319; DOI: https://doi.org/10.1124/jpet.302.1.314
  • You have access
    High Salt Intake Impairs Vascular Nitric Oxide/Cyclic Guanosine Monophosphate System in Spontaneously Hypertensive Rats
    Satomi Kagota, Akiko Tamashiro, Yu Yamaguchi, Kazuki Nakamura and Masaru Kunitomo
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 344-351; DOI: https://doi.org/10.1124/jpet.302.1.344
  • You have access
    Presynaptic Muscarinic M2-Receptor-Mediated Inhibition of N-Type Ca2+ Channels in Cultured Sphenopalatine Ganglion: Direct Evidence for Acetylcholine Inhibition of Cerebral Nitrergic Neurogenic Vasodilation
    J. Liu, M. S. Evans and T. J.-F. Lee
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 397-405; DOI: https://doi.org/10.1124/jpet.302.1.397

CELLULAR AND MOLECULAR

  • You have access
    Biochemistry and Pharmacology of Epitope-Tagged α1-Adrenergic Receptor Subtypes
    Aleksandra Vicentic, Anna Robeva, George Rogge, Michelle Uberti and Kenneth P. Minneman
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 58-65; DOI: https://doi.org/10.1124/jpet.302.1.58
  • You have access
    A Novel cAMP-Stimulated Pathway in Protein Phosphatase 2A Activation
    Marina S. Feschenko, Elizabeth Stevenson, Angus C. Nairn and Kathleen J. Sweadner
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 111-118; DOI: https://doi.org/10.1124/jpet.302.1.111
  • You have access
    Pharmacology ofN-(3,5-Dichloro-1-oxido-4-pyridinyl)-8-methoxy-2-(trifluoromethyl)-5-quinoline Carboxamide (SCH 351591), a Novel, Orally Active Phosphodiesterase 4 Inhibitor
    M. Motasim Billah, Nicola Cooper, Michael Minnicozzi, Julie Warneck, Peng Wang, John A. Hey, William Kreutner, Charles A. Rizzo, Sidney R. Smith, Simon Young, Richard W. Chapman, Hazel Dyke, Nang-Yang Shih, John J. Piwinski, Francis M. Cuss, John Montana, Ashit K. Ganguly and Robert W. Egan
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 127-137; DOI: https://doi.org/10.1124/jpet.302.1.127
  • You have access
    Differential Internalization of the Prostaglandin F2α Receptor Isoforms: Role of Protein Kinase C and Clathrin
    Dinesh Srinivasan, Hiromichi Fujino and John W. Regan
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 219-224; DOI: https://doi.org/10.1124/jpet.302.1.219
  • You have access
    Blockade of Human Cardiac Potassium Channel Human Ether-a-go-go-Related Gene (HERG) by Macrolide Antibiotics
    Walter A. Volberg, Bryan J. Koci, Weiguo Su, Jing Lin and Jun Zhou
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 320-327; DOI: https://doi.org/10.1124/jpet.302.1.320
  • You have access
    A Novel Phenylaminotetralin Radioligand Reveals a Subpopulation of Histamine H1 Receptors
    Raymond G. Booth, Nader H. Moniri, Remko A. Bakker, Neepa Y. Choksi, William B. Nix, Henk Timmerman and Rob Leurs
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 328-336; DOI: https://doi.org/10.1124/jpet.302.1.328
  • You have access
    Putative Conventional Protein Kinase C Inhibitor Gödecke 6976 [12-(2-Cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] Stimulates Transglutaminase Activity in Primary Mouse Epidermal Keratinocytes
    Brian A. Shapiro, Sagarika Ray, EunMi Jung, William T. Allred and Wendy B. Bollag
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 352-358; DOI: https://doi.org/10.1124/jpet.302.1.352

CHEMOTHERAPY, ANTIBIOTICS, AND GENE THERAPY

  • You have access
    Schedule-Dependent Interaction between Vinblastine and Cisplatin in Ehrlich Ascites Tumors in Mice
    Maja Čemažar, Marija Auersperg, Janez Ščančar, Irena Srebotnik Kirbiš, Ana Pogačnik and Gregor Serša
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 337-343; DOI: https://doi.org/10.1124/jpet.302.1.337

ENDOCRINE AND REPRODUCTIVE

  • You have access
    Rapid Inhibition of Thyroxine-Induced Bone Resorption in the Rat by an Orally Active Vitronectin Receptor Antagonist
    Sandra J. Hoffman, Janice Vasko-Moser, William H. Miller, Michael W. Lark, Maxine Gowen and George Stroup
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 205-211; DOI: https://doi.org/10.1124/jpet.302.1.205
  • You have access
    Skeletal Efficacy with Parathyroid Hormone in Rats Was Not Entirely Beneficial with Long-Term Treatment
    M. Sato, Y. L. Ma, J. M. Hock, M. S. Westmore, J. Vahle, A. Villanueva and C. H. Turner
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 304-313; DOI: https://doi.org/10.1124/jpet.302.1.304

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

  • You have access
    Cisplatin-Induced Renal Cell Apoptosis: Caspase 3-Dependent and -Independent Pathways
    Brian S. Cummings and Rick G. Schnellmann
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 8-17; DOI: https://doi.org/10.1124/jpet.302.1.8
  • You have access
    Alcohol Activates Activator Protein-1 and Mitogen-Activated Protein Kinases in Rat Pancreatic Stellate Cells
    Atsushi Masamune, Kazuhiro Kikuta, Masahiro Satoh, Akihiko Satoh and Tooru Shimosegawa
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 36-42; DOI: https://doi.org/10.1124/jpet.302.1.36
  • You have access
    Cytoprotective Properties of Novel Nonpeptide Calpain Inhibitors in Renal Cells
    Xiuli Liu, Jay F. Harriman and Rick G. Schnellmann
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 88-94; DOI: https://doi.org/10.1124/jpet.302.1.88

INFLAMMATION AND IMMUNOPHARMACOLOGY

  • You have access
    Nonsteroidal Anti-Inflammatory Drugs Induce Apoptosis in Association with Activation of Peroxisome Proliferator-Activated Receptor γ in Rheumatoid Synovial Cells
    Ryuta Yamazaki, Natsuko Kusunoki, Takeshi Matsuzaki, Shusuke Hashimoto and Shinichi Kawai
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 18-25; DOI: https://doi.org/10.1124/jpet.302.1.18
  • You have access
    Inhibition of Inducible Nitric-Oxide Synthase Expression by Silymarin in Lipopolysaccharide-Stimulated Macrophages
    Jong S. Kang, Young J. Jeon, Hwan M. Kim, Seung H. Han and Kyu-Hwan Yang
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 138-144; DOI: https://doi.org/10.1124/jpet.302.1.138
  • You have access
    α4β7/α4β1Dual Integrin Antagonists Block α4β7-Dependent Adhesion under Shear Flow
    Linda A. Egger, Usha Kidambi, Jin Cao, Gail Van Riper, Ermengilda McCauley, Richard A. Mumford, Suzanne Amo, Russell Lingham, Thomas Lanza, Linus S. Lin, Stephen E. de Laszlo, David N. Young, Ihor E. Kopka, Sharon Tong, Bill Pikounis, Evelyn Benson, Sarah Warwood, Robert F. Bargatze, William K. Hagmann, John A. Schmidt and Patricia A. Detmers
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 153-162; DOI: https://doi.org/10.1124/jpet.302.1.153
  • You have access
    Low-Molecular-Weight Heparins Inhibit CCL21-Induced T Cell Adhesion and Migration
    Kent W. Christopherson, James J. Campbell, Jeffrey B. Travers and Robert A. Hromas
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 290-295; DOI: https://doi.org/10.1124/jpet.302.1.290
  • You have access
    (E)-2(R)-[1(S)-(Hydroxycarbamoyl)-4-phenyl-3-butenyl]-2′-isobutyl-2′-(methanesulfonyl)-4-methylvalerohydrazide (Ro 32-7315), a Selective and Orally Active Inhibitor of Tumor Necrosis Factor-α Convertase
    G. Beck, G. Bottomley, D. Bradshaw, M. Brewster, M. Broadhurst, R. Devos, C. Hill, W. Johnson, H.-J. Kim, S. Kirtland, J. Kneer, N. Lad, R. Mackenzie, R. Martin, J. Nixon, G. Price, A. Rodwell, F. Rose, J.-P. Tang, D. S. Walter, K. Wilson and E. Worth
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 390-396; DOI: https://doi.org/10.1124/jpet.302.1.390

NEUROPHARMACOLOGY

  • You have access
    Modulation of Blood-Brain Barrier Dysfunction and Neurological Deficits during Acute Experimental Allergic Encephalomyelitis by theN-Methyl-d-aspartate Receptor Antagonist Memantine
    Carolyn Paul and Christopher Bolton
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 50-57; DOI: https://doi.org/10.1124/jpet.302.1.50
  • You have access
    Pharmacological Activity of Fatty Acid Amides Is Regulated, but Not Mediated, by Fatty Acid Amide Hydrolase in Vivo
    Aron H. Lichtman, E. Gregory Hawkins, Graeme Griffin and Benjamin F. Cravatt
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 73-79; DOI: https://doi.org/10.1124/jpet.302.1.73
  • You have access
    A Single Dose of Monoclonal Anti-Phencyclidine IgG Offers Long-Term Reductions in Phencyclidine Behavioral Effects in Rats
    J. Shane Hardin, William D. Wessinger, Galen R. Wenger, Joel W. Proksch, Elizabeth M. Laurenzana and S. Michael Owens
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 119-126; DOI: https://doi.org/10.1124/jpet.302.1.119
  • You have access
    Pharmacological Evidence Supporting a Role for Central Corticotropin-Releasing Factor2 Receptors in Behavioral, but not Endocrine, Response to Environmental Stress
    Mary Ann Pelleymounter, Margaret Joppa, Nicholas Ling and Alan C. Foster
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 145-152; DOI: https://doi.org/10.1124/jpet.302.1.145
  • You have access
    A Novel N-Methyl-d-aspartate Receptor Open Channel Blocker with in Vivo Neuroprotectant Activity
    Rosa Planells-Cases, Carmina Montoliu, Marc Humet, Asia M. Fernández, Carolina Garcı́a-Martı́nez, Elvira Valera, Jaime M. Merino, Enrique Pérez-Payá, Angel Messeguer, Vicente Felipo and Antonio Ferrer-Montiel
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 163-173; DOI: https://doi.org/10.1124/jpet.302.1.163
  • You have access
    The Selective Serotonin Reuptake Inhibitor Citalopram Induces the Storage of Serotonin in Catecholaminergic Terminals
    Heberto Suarez-Roca and Luigi X. Cubeddu
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 174-179; DOI: https://doi.org/10.1124/jpet.302.1.174
  • You have access
    Therapeutic Intervention in Mice Deficient for Succinate Semialdehyde Dehydrogenase (γ-Hydroxybutyric Aciduria)
    Maneesh Gupta, Rachel Greven, Erwin E. W. Jansen, Cornelis Jakobs, Boris M. Hogema, Wolfgang Froestl, O. Carter Snead, Hilke Bartels, Markus Grompe and K. Michael Gibson
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 180-187; DOI: https://doi.org/10.1124/jpet.302.1.180
  • You have access
    Profound Spinal Tolerance after Repeated Exposure to a Highly Selective μ-Opioid Peptide Agonist: Role of δ-Opioid Receptors
    Guo-Min Zhao, Dunli Wu, Yi Soong, Megumi Shimoyama, Irena Berezowska, Peter W. Schiller and Hazel H. Szeto
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 188-196; DOI: https://doi.org/10.1124/jpet.302.1.188
  • You have access
    Methyllycaconitine Is a Potent Antagonist of α-Conotoxin-MII-Sensitive Presynaptic Nicotinic Acetylcholine Receptors in Rat Striatum
    Adrian J. Mogg, Paul Whiteaker, J. Michael McIntosh, Michael Marks, Allan C. Collins and Susan Wonnacott
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 197-204; DOI: https://doi.org/10.1124/jpet.302.1.197
  • You have access
    Enhancement of l-Cystine Transport Activity and Its Relation to xCT Gene Induction at the Blood-Brain Barrier by Diethyl Maleate Treatment
    Ken-ichi Hosoya, Masatoshi Tomi, Sumio Ohtsuki, Hitomi Takanaga, Shigeki Saeki, Yoshikatsu Kanai, Hitoshi Endou, Mikihiko Naito, Takashi Tsuruo and Tetsuya Terasaki
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 225-231; DOI: https://doi.org/10.1124/jpet.302.1.225
  • You have access
    Reconsideration of 5-Hydroxytryptamine (5-HT)7Receptor Distribution Using [3H]5-Carboxamidotryptamine and [3H]8-Hydroxy-2-(di-n-propylamino)tetraline: Analysis in Brain of 5-HT1A Knockout and 5-HT1A/1B Double-Knockout Mice
    Pascal Bonaventure, Diane Nepomuceno, Annette Kwok, Wenying Chai, Xavier Langlois, Rene Hen, Kimberly Stark, Nicholas Carruthers and Timothy W. Lovenberg
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 240-248; DOI: https://doi.org/10.1124/jpet.302.1.240
  • You have access
    Hydrolysis of N-Methyl-d-aspartate Receptor-Stimulated cAMP and cGMP by PDE4 and PDE2 Phosphodiesterases in Primary Neuronal Cultures of Rat Cerebral Cortex and Hippocampus
    Neesha U. Suvarna and James M. O'Donnell
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 249-256; DOI: https://doi.org/10.1124/jpet.302.1.249
  • You have access
    C-Terminal Heptapeptide of Gastrin Inhibits Astrocytomas Motility by Interacting with a New Gastrin Binding Site
    Julie Pannequin, Catherine Oiry, Caroline Morel, Jérôme Kucharczak, Isabelle Camby, Robert Kiss, Didier Gagne, Jean-Claude Galleyrand and Jean Martinez
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 274-282; DOI: https://doi.org/10.1124/jpet.302.1.274
  • You have access
    Characterization of the Diarylether Sulfonylester (−)-(R)-3-(2-Hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a Potent Cannabinoid Receptor Agonist with Neuroprotective Properties
    Frank Mauler, Joachim Mittendorf, Ervin Horváth and Jean de Vry
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 359-368; DOI: https://doi.org/10.1124/jpet.302.1.359
  • You have access
    8-Carboxamidocyclazocine: A Long-Acting, Novel Benzomorphan
    Jean M. Bidlack, Dana J. Cohen, Jay P. McLaughlin, Rongliang Lou, Yingchun Ye and Mark P. Wentland
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 374-380; DOI: https://doi.org/10.1124/jpet.302.1.374
  • You have access
    Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors
    Kevin D. Burris, Thaddeus F. Molski, Cen Xu, Elaine Ryan, Katsura Tottori, Tetsuro Kikuchi, Frank D. Yocca and Perry B. Molinoff
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 381-389; DOI: https://doi.org/10.1124/jpet.102.033175

TOXICOLOGY

  • You have access
    Oxidative Stress and Mitochondrial-Mediated Apoptosis in Dopaminergic Cells Exposed to Methylcyclopentadienyl Manganese Tricarbonyl
    Masashi Kitazawa, Jarrad R. Wagner, Michael L. Kirby, Vellareddy Anantharam and Anumantha G. Kanthasamy
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 26-35; DOI: https://doi.org/10.1124/jpet.302.1.26
  • You have access
    Bisphenol A Inhibits Cl− Secretion by Inhibition of Basolateral K+ Conductance in Human Airway Epithelial Cells
    Yasushi Ito, Shinji Sato, Masami Son, Masashi Kondo, Hiroaki Kume, Kenzo Takagi and Kenichi Yamaki
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 80-87; DOI: https://doi.org/10.1124/jpet.302.1.80
  • You have access
    4-Hydroxynonenal Decreases Interleukin-6 Expression and Protein Production in Primary Rat Kupffer Cells by Inhibiting Nuclear Factor-κB Activation
    Stephen W. Luckey, Melinda Taylor, Brante P. Sampey, Robert I. Scheinman and Dennis R. Petersen
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 296-303; DOI: https://doi.org/10.1124/jpet.102.033522

Erratum

  • You have access
    Correction to “Functional Selectivity of Dopamine Receptor Agonists. I. Selective Activation of Postsynaptic Dopamine D2 Receptors Linked to Adenylate Cyclase”
    Journal of Pharmacology and Experimental Therapeutics July 2002, 302 (1) 406;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 302 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 302, Issue 1
1 Jul 2002
  • Table of Contents
  • Index by author
Sign up for alerts

Jump to

  • PERSPECTIVES IN PHARMACOLOGY
  • ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION
  • BEHAVIORAL PHARMACOLOGY
  • CARDIOVASCULAR
  • CELLULAR AND MOLECULAR
  • CHEMOTHERAPY, ANTIBIOTICS, AND GENE THERAPY
  • ENDOCRINE AND REPRODUCTIVE
  • GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
  • INFLAMMATION AND IMMUNOPHARMACOLOGY
  • NEUROPHARMACOLOGY
  • TOXICOLOGY
  • Erratum
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics